Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021:1301:41-57.
doi: 10.1007/978-3-030-62026-4_4.

The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis

Affiliations
Review

The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis

Naiara Santana-Codina et al. Adv Exp Med Biol. 2021.

Abstract

Nuclear receptor coactivator 4 (NCOA4) is a selective cargo receptor that mediates the autophagic degradation of ferritin, the cytosolic iron storage complex, in a process known as ferritinophagy. NCOA4-mediated ferritinophagy is required to maintain intracellular and systemic iron homeostasis and thereby iron-dependent physiologic processes such as erythropoiesis. Given this role of ferritinophagy in regulating iron homeostasis, modulating NCOA4-mediated ferritinophagic flux alters sensitivity to ferroptosis, a non-apoptotic iron-dependent form of cell death triggered by peroxidation of polyunsaturated fatty acids (PUFAs). A role for ferroptosis has been established in the pathophysiology of cancer and neurodegeneration; however, the importance of ferritinophagy in these pathologies remains largely unknown. Here, we review the available evidence on biochemical regulation of NCOA4-mediated ferritinophagy and its role in modulating sensitivity to innate and induced ferroptosis in neurodegenerative diseases and cancer. Finally, we evaluate the potential of modulating ferritinophagy in combination with ferroptosis inducers as a therapeutic strategy.

Keywords: Autophagy; Cancer; Ferritin; Ferritinophagy; NCOA4; Neurodegeneration.

PubMed Disclaimer

References

    1. Abdalkader M, Lampinen R, Kanninen KM et al (2018) Targeting Nrf2 to suppress ferroptosis and mitochondrial dysfunction in neurodegeneration. Front Neurosci 12:466 - PubMed - PMC - DOI
    1. Alen P, Claessens F, Schoenmakers E et al (1999) Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol 13:117–128 - PubMed - PMC
    1. Alvarez SW, Sviderskiy VO, Terzi EM et al (2017) NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis. Nature 551:639–643 - PubMed - PMC - DOI
    1. Asano T, Komatsu M, Yamaguchi-Iwai Y et al (2011) Distinct mechanisms of ferritin delivery to lysosomes in iron-depleted and iron-replete cells. Mol Cell Biol 31:2040–2052 - PubMed - PMC - DOI
    1. Atri A (2019) The Alzheimer’s disease clinical spectrum: diagnosis and management. Med Clin North Am 103:263–293 - PubMed - DOI - PMC

LinkOut - more resources